Engineered mesenchymal stem cell-derived extracellular vesicles: kill tumors and protect organs

Area of Science:

• Oncology
• Biotechnology
• Regenerative Medicine

Background:

• Solid tumors are a leading cause of cancer mortality, posing significant treatment challenges.
• Current therapies like surgery, radiotherapy, and chemotherapy have limitations including side effects and drug resistance.
• Improved precision and organ repair are crucial for effective solid tumor management.

Purpose of the Study:

• To review recent advancements in using mesenchymal stem cell extracellular vesicles (MSC-EVs) for solid tumor therapy.
• To discuss engineering strategies for enhancing MSC-EV efficacy in solid tumor suppression.
• To inspire novel therapeutic approaches for solid tumors using MSC-EVs.

Main Methods:

• Review of current literature on MSC-EVs in solid tumor treatment.
• Analysis of MSC-EV properties, including tissue regeneration and safety.
• Exploration of engineering strategies to improve MSC-EV therapeutic potential.

Main Results:

• MSC-EVs derived from mesenchymal stem cells (MSCs) promote tissue regeneration.
• MSC-EVs exhibit favorable safety, stability, and tumor penetration.
• Engineering strategies can enhance the therapeutic efficacy of MSC-EVs.

Conclusions:

• MSC-EVs represent a promising extracellular therapeutic modality for solid tumors.
• Further research into MSC-EV engineering can optimize their application in oncology.
• MSC-EVs offer a potential new avenue for effective solid tumor treatment and suppression.